Evidence-Based Medicine Guidelines
Oxcarbazepine versus phenytoin monotherapy for epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oxcarbazepine Versus Phenytoin Monotherapy for Epilepsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456048/all/Oxcarbazepine_versus_phenytoin_monotherapy_for_epilepsy.
Oxcarbazepine versus phenytoin monotherapy for epilepsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456048/all/Oxcarbazepine_versus_phenytoin_monotherapy_for_epilepsy. Accessed November 30, 2023.
Oxcarbazepine versus phenytoin monotherapy for epilepsy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456048/all/Oxcarbazepine_versus_phenytoin_monotherapy_for_epilepsy
Oxcarbazepine Versus Phenytoin Monotherapy for Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456048/all/Oxcarbazepine_versus_phenytoin_monotherapy_for_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oxcarbazepine versus phenytoin monotherapy for epilepsy
ID - 456048
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456048/all/Oxcarbazepine_versus_phenytoin_monotherapy_for_epilepsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
